Multiple Sclerosis Tied to Increased Risk for Stroke, CVD, Death Multiple sclerosis (MS) is associated with an increased risk for acute coronary syndrome (ACS), stroke, and death, a finding that is unexplained by traditional risk factors, new research suggests.
Diastolic Dysfunction a Common Risk Factor for Cognitive Decline Diastolic dysfunction, a common and often undiagnosed condition in older individuals, could be contributing to the increasing burden of cognitive decline, a new study suggests.
Exploring Postinfarction Reentrant Ventricular Tachycardia With Entrainment Mapping Ventricular tachycardia late after myocardial infarction is usually due to reentry in the infarct region. These reentry circuits can be large, complex and difficult to define, impeding study in the electrophysiology laboratory and making catheter ablation difficult.
Appeals to “stay at home” during COVID-19 do not apply to heart attacks People experiencing heart attacks should immediately phone the emergency services – even during the COVID-19 pandemic. The urgent call from the European Society of Cardiology (ESC) comes as hospitals in Europe and beyond report dramatic reductions in heart attack admissions.
Vitamin K Antagonists and Osteoporotic Fractures: Insights From Comparisons With the NOACs Vitamin K antagonists (VKAs; warfarin mostly, but also acenocoumarol, phenprocoumon, phenindione, and fluindione) have been a cornerstone in medicine as the first and the only available oral anticoagulants (OACs) for clinical use for over half a century.
High haemoglobin A1c level is a possible risk factor for ventricular fibrillation in sudden cardiac arrest among non-diabetic individuals in the general population This study aimed to establish whether higher levels of glycated haemoglobin (HbA1c) are associated with increased sudden cardiac arrest (SCA) risk in non-diabetic individuals.
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes (22%).
Mitral Regurgitation Management Focused Update: Key Points This is an update to the 2017 American College of Cardiology (ACC) expert consensus decision pathway (ECDP) on the management of mitral regurgitation (MR).
Europe to personalise prevention of second heart attacks Cardiovascular disease (CVD) is the top cause of death in Europe and worldwide, accounting for 47% of deaths in women and 39% of deaths in men.1 CVD costs the EU more than €210 billion a year,2 a sum expected to escalate with an ageing population and the cost of novel therapies.
Eating meat, including chicken, linked to heart disease risk in study Eating meat has been linked to heart disease in the latest study to suggest the food could pose some risk to our health.
Dear colleagues! I welcome you on behalf of the Organizing Committee of the XI International Forum for Cardiology and Internal Medicine, which will be held from March 22 to 24, 2022 in Moscow.
Polypill Shows LDL-Lowering Advantage in High-risk Primary Prevention Patients: VULCANO Key Takeaways The CNIC (Centro Nacional de Investigaciones Cardiovasculares) polypill contains acetylsalicylic acid (100 mg), atorvastatin (30 mg or 40 mg), and ramipril (2.5 mg, 5 mg, or 10 mg), and is the only polypill for cardiovascular disease (CVD) currently marketed in European countries.
Current Overview on Hypercoagulability in COVID-19 The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboembolic complications, especially in critically ill patients.
ESC/EACTS to Review Left Main Revascularization Guidance Patrice Wendling The European Society of Cardiology and European Association for Cardiothoracic Surgery (ESC/EACTS) have announced they will review their joint recommendations for left main coronary artery disease in light of emerging data.
Russian National Congress of Cardiology 2020 CONFERENCE NEWS
World Heart Day On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.
European Society of Cardiology (ESC) Congress 2020. CONFERENCE NEWS
Major Indexing Service Calls Out Cardiology Journals for Self-Citation More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.
Novel Lipid Therapies: 5 Things to Know The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.
COVID-19 and cardiovascular diseases: main aspects Igor S. Yavelov MD, PhD, Professor of cardiology